Information Provided By:
Fly News Breaks for May 16, 2019
HI, CVSI, TTOO, ICHR, PAR
May 16, 2019 | 10:15 EDT
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Jefferies starts 'underappreciated' Par Technology (PAR) with Buy rating. 2. Ichor Holdings (ICHR) initiated with a Buy at B. Riley FBR. 3. T2 Biosystems (TTOO) initiated with a Buy at Alliance Global Partners. 4. CV Sciences (CVSI) initiated with a Buy at Roth Capital. 5. Hillenbrand (HI) initiated with a Buy at Buckingham. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
News For PAR;ICHR;TTOO;CVSI;HI From the Last 2 Days
CVSI
Mar 28, 2024 | 11:32 EDT
In this edition of "Rising High," The Fly conducted an exclusive interview with Sundie Seefried, founder and chief executive officer of Safe Harbor Financial (SHFS), a financial services provider to the regulated cannabis industry. Here are some... To see the rest of the story go to thefly.com. See Story Here
TTOO
Mar 28, 2024 | 09:08 EDT
T2 Biosystems announced that its multi-year capital equipment supplier agreement with Vizient has been extended through March 31, 2025. The products covered under the contract with Vizient include the T2Dx Instrument, the T2Bacteria Panel and the T2Candida Panel, which detect sepsis-causing bacterial and fungal pathogens directly from whole blood. "We are pleased to extend our multi-year agreement with Vizient, the nation's largest group purchasing organization. This reiterates the continued value that our products offer to patients suspected of sepsis," stated John Sperzel, Chairman and CEO of T2 Biosystems. "We believe there is a strong need for hospitals to have more effective rapid diagnostics that enable faster targeted therapy and this contract with Vizient improves hospitals' access to our life-saving technology."